Neonatal Hypoxic Ischemic Encephalopathy
8
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Neonatal Brain Ultrasound With CEUS and Elastography
Feasibility and Safety of Intranasally Administered Breast Milk in HIE
Intranasal Breast Milk Therapy in HIE
Erythropoietin in HIE Neonate
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy
Antenatal and Intrapartum Risk Factors Associated With Neonatal Hypoxic Ischemic Encephalopathy
Neonatal Hypoxic Ischemic Encephalopathy:Early Diagnosis and Management of Comorbidities